ArticleRespiratory medicine case reports2026

Successful Re-challenge of zongertinib following erythema multiforme-like drug eruption in a patient with HER2-mutant non-small cell lung cancer.

Kodai Kawamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.